Evolution of SARS-CoV-2 – Delta, Omicron, and More Greek Alphabet(s)

Columbia University's Zuckerman Institute

K. Sato

Immunity of SARS-CoV-2 Vaccines Against Omicron

Columbia University's Zuckerman Institute

D. Barouch

Factors That Anticipate Post Acute COVID-19 Sequelae

Columbia University's Zuckerman Institute

J. R Heath

Disruption of Nuclear Architecture as a Mechanism for COVID-19 Induc…

Columbia University's Zuckerman Institute

S. Lomvardas

Do the Placenta and Fetus Respond to SARS-CoV-2 Infection During Pre…

Columbia University's Zuckerman Institute

N. Gómez-López

Tracking SARS-CoV-2 Variants in the UK

Columbia University's Zuckerman Institute

E. Thomson

Exosomal ACE2 Neutralizes Broad Variants of SARS-CoV-2

Columbia University's Zuckerman Institute

L. El-Shennawy

In Vitro Pipelines for the Discovery of SARS-CoV-2 Antivirals

Columbia University's Zuckerman Institute

D. C. Schultz

Alzheimer’s-like Signaling in Brains of COVID-19 Patients

Columbia University's Zuckerman Institute

A. R. Marks

Decreased SARS-CoV-2 Viral Load Following Inoculation with the BNT16…

Columbia University's Zuckerman Institute

M. Levine

SARS-CoV-2 Variants Alpha to Omicron: The Response of T-Cells

Columbia University's Zuckerman Institute

A. Grifoni

T-Cell Responses in Acute and Persistent COVID-19

Columbia University's Zuckerman Institute

A. Huang

The Legacy of Maternal SARS-CoV-2 Infection on the Immunology of the…

Columbia University's Zuckerman Institute

D. Gibbons

Can the Neuropathology in COVID-19 Brains Explain the Neuropsychiatr…

Columbia University's Zuckerman Institute

J. E. Goldman

Transitioning to the Next Phase of the Pandemic: What Can Implementa…

Columbia University's Zuckerman Institute

W. Branch-Elliman

What Is the Link Between COVID-19 and Obesity?

Columbia University's Zuckerman Institute

T. Mclaughlin

A Single Dose SARS-CoV-2 Antiviral Intervention With a High Barrier …

Columbia University's Zuckerman Institute

L. Weinberger

Long-Term Outcomes of SARS-CoV-2 Infection: Immunological Memory and…

Columbia University's Zuckerman Institute

O. Boyman

Local and Systemic Responses to SARS-CoV-2 Infection in Children and…

Columbia University's Zuckerman Institute

K. Meyer

Aberrant Myeloid Cell Responses in Severe COVID-19

Columbia University's Zuckerman Institute

L. Erik Sander

Novel Approaches to Testing for SARS-CoV-2 Infection and Immunity

Columbia University's Zuckerman Institute

M. Ott

Mental Health Concerns During the COVID-19 Pandemic as Revealed by H…

Columbia University's Zuckerman Institute

V. Klotzbücher

Neutralizing Antibodies Against Pandemic Viruses

Columbia University's Zuckerman Institute

P. J. Bjorkman

Emergence and Phenotype of SARS-CoV-2 Omicron

Columbia University's Zuckerman Institute

P. Moore

A Global Effort to Dissect the Human Genetic Basis of Resistance to …

Columbia University's Zuckerman Institute

A. N. Spaan

Humoral Immune Responses to SARS-CoV-2 Infection or Vaccination

Columbia University's Zuckerman Institute

C. Gaebler

Pre-existing Polymerase-specific T Cells Expand in Abortive Seronega…

Columbia University's Zuckerman Institute

M. Maini

SARS-CoV-2 Re-Infections: Lessons From Other Coronaviruses

Columbia University's Zuckerman Institute

L. Van Der Hoek

Striking Antibody Evasion Manifested by the Omicron Variant of SARS-…

Columbia University's Zuckerman Institute

D. Ho

Antiviral Strategy for SARS-CoV-2: Lethal Mutagenesis With Molnupira…

Columbia University's Zuckerman Institute

R. Swanstrom

Protective Immunity From T-Cells to SARS-CoV-2 in Previously Infecte…

Columbia University's Zuckerman Institute

P. Klenerman

What Can Sequence Based Analyses of Natural Selection of SARS-CoV-2 …

Columbia University's Zuckerman Institute

S. L. Kosakovsky Pond

Understanding the Transmission Dynamics of SARS-CoV-2 Using Mathemat…

Columbia University's Zuckerman Institute

S. Pei

Structure Guided Design of Coronavirus Vaccines

Columbia University's Zuckerman Institute

D. Veesler

Network Based Identification and Pharmacological Targeting of Host C…

Columbia University's Zuckerman Institute

M. J. Alvarez

Pandemic-Scale Phylogenomics for SARS-CoV-2 and Beyond

Columbia University's Zuckerman Institute

R. Corbett-Detig

Autoantibodies in COVID-19: Impact on Disease Outcomes in COVID-19 P…

Columbia University's Zuckerman Institute

A. Ring

COVID-19: Building Vaccine Confidence With an Evidence Based Approach

Columbia University's Zuckerman Institute

S. Friedhoff

Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)

Columbia University's Zuckerman Institute

I. Nazy

T Cell Responses Induced by SARS-CoV-2 mRNA Vaccination: How Much Pr…

Columbia University's Zuckerman Institute

M. Hofmann

B Cell Response to SARS-CoV-2 Vaccination in Humans

Columbia University's Zuckerman Institute

A. H. Ellebedy

SARS-CoV-2 Natural Infection Versus Vaccination: How Does the Streng…

Columbia University's Zuckerman Institute

D. Wesemann

COVID-19 Vaccination in Previously Infected Individuals

Columbia University's Zuckerman Institute

N. Shrestha

Mapping a Pandemic: SARS-CoV-2 Seropositivity in the United States

Columbia University's Zuckerman Institute

K. Sadtler

SARS-CoV-2: Replication and Sensitivity of the Delta Variant to Anti…

Columbia University's Zuckerman Institute

O. Schwartz

COVID-19: Evaluating the Effectiveness of Different Interventions Fr…

Columbia University's Zuckerman Institute

K. Gostic

COVID-19: What Level of Immune Response Is Sufficient to Protect Us …

Columbia University's Zuckerman Institute

M. P. Davenport

COVID-19: What Is the Risk of Developing Immune Thrombocytopenia (IT…

Columbia University's Zuckerman Institute

J. Bussel

SARS-CoV-2: Can Cytokines’ Level and Their Connection With Immune Ce…

Columbia University's Zuckerman Institute

P. Brodin

COVID-19: Can CoVac-1 Induce Higher SARS-CoV-2-Specific T-Cell Respo…

Columbia University's Zuckerman Institute

J. Walz

COVID-19 Indoor Safety Guidelines for Airborne Transmission (July 20…

Columbia University's Zuckerman Institute

M. Bazant

Integrating Human and Single Cell Variations in COVID-19

Columbia University's Zuckerman Institute

J. Tsang

Long COVID-19: Do Patients Who Have Recovered From Acute Respiratory…

Columbia University's Zuckerman Institute

Z. Al-Aly

COVID-19 Pathology to Therapy: Are Calcium-Activated Chloride Channe…

Columbia University's Zuckerman Institute

M. Giacca

Are Chromatin-Based Inhibition of Inflammatory Gene Programs a Viabl…

Columbia University's Zuckerman Institute

I. Marazzi

How Do Pre-Existing Memory B and T Cells Relate to Susceptibility an…

Columbia University's Zuckerman Institute

S. E. Hensley

Effect of Bardoxolone in Participants with SARS-CoV-2: Can It Manipu…

Columbia University's Zuckerman Institute

T. Pietschmann

Is the Transmembrane Protein 41B (TMEM41B) a Potential Target to Fig…

Columbia University's Zuckerman Institute

W. Schneider, H. Hoffman

Predicting Future Zoonotic Events: How Can SARS-CoV-2 Infect Humans …

Columbia University's Zuckerman Institute

N. Elde

COVID Data Models (CoDatMo): Researchers Pool Data of COVID-19 Contr…

Columbia University's Zuckerman Institute

B. Beldwin

Which SARS-CoV-2 Variant is of Most Concern in Vaccine Neutralizatio…

Columbia University's Zuckerman Institute

P. Shi

Detection of COVID-19 Using Wearables​​​​​​​: Can Wearable Devices P…

Columbia University's Zuckerman Institute

M. Snyder

Resurgent COVID-19: How Does Age Prioritized Vaccination Affect the …

Columbia University's Zuckerman Institute

O. Ratmann

SARS-CoV-2 Evolution During Treatment of Chronic Infection: Is Chron…

Columbia University's Zuckerman Institute

R. Gupta

Identification of SARS-CoV-2 Host Factors Using Multi-Scale Function…

Columbia University's Zuckerman Institute

J. Poirier

SARS-CoV-2 mRNA Vaccine: How Can This New Vaccine Help Future Vaccin…

Columbia University's Zuckerman Institute

K. Corbett

SARS-CoV-2 Transmission: What Is the Role of Clusters and Supersprea…

Columbia University's Zuckerman Institute

B. Macinnis

COVID-19 & Computational Epidemiology: How Can Models Provide Real F…

Columbia University's Zuckerman Institute

A. Vespignani

How Structured Is the SARS-CoV-2 Genome? What Have We Learned and Wh…

Columbia University's Zuckerman Institute

A. Pyle

SARS-CoV-2 Specific T Cells: What Is Their Role During the First 30 …

Columbia University's Zuckerman Institute

A. Bertoletti

Tackling COVID-19: Does Alpaca Nanobody Neutralize SARS-CoV-2?

Columbia University's Zuckerman Institute

G. Mclnerney

COVID-19 Backup Vaccine: Can Exposure to HCoV Viruses Reduce the Sev…

Columbia University's Zuckerman Institute

A. Thiel

SARS-CoV-2 Neutralizing Antibodies & Vaccine: How Do We Extract Anti…

Columbia University's Zuckerman Institute

D. Burton

COVID-19 Prevention: Can Coronavirus 3CL Proteases Prevent Protease-…

Columbia University's Zuckerman Institute

S. Resnick

Simple, Cheap & Rapid COVID-19 Tests: How Important Are They for Saf…

Columbia University's Zuckerman Institute

D. Ho

SARS-CoV-2 in Companion Animals: What Are Susceptibility, Transmissi…

Columbia University's Zuckerman Institute

J. Richt

Severity Prediction in COVID-19: Can We Predict Disease Severity & O…

Columbia University's Zuckerman Institute

J. Lee

Corona & Corona-Like Viruses: What Kind of Virus Is γ-CoV Which Comm…

Columbia University's Zuckerman Institute

B. Neuman

COVID-19: What Are the Benefits of Steroid + Antiviral Combination? …

Columbia University's Zuckerman Institute

D. Jin

SARS-CoV-2 Transmission: What Aerosol Concentration and Size Distrib…

Columbia University's Zuckerman Institute

Y. Li

COVID-19 Resilience Plan (October Update): Is the End of the Pandemi…

Columbia University's Zuckerman Institute

I. Redlener

SARS-CoV-2 Replication-Transcription Complex: What Is the Structural…

Columbia University's Zuckerman Institute

S. Darst

SARS-CoV-2 Replication & Transcription: What Is the Biological Role …

Columbia University's Zuckerman Institute

E. Campbell

Remdesivir vs. 3CLpro Inhibitor in SARS-CoV-2 Battle: Does 3CL Prote…

Columbia University's Zuckerman Institute

M. Dittmann

Sex Differences in COVID-19: Is There Any Difference in Viral Load o…

Columbia University's Zuckerman Institute

A. Iwasaki

SARS-CoV-2 Immune Response: What Are the Disease Outcomes & Differen…

Columbia University's Zuckerman Institute

A. Iwasaki

COVID-19 SalivaDirectTM Test With 94.1% Accuracy: Will This Simple a…

Columbia University's Zuckerman Institute

A. Wyllie

Prefusion-Stabilized SARS-CoV-2 Spikes: Will High-Yield Production o…

Columbia University's Zuckerman Institute

J. Mclellan

SARS-CoV-2 Structural Analysis: Why is Cryo Electron Tomography Good…

Columbia University's Zuckerman Institute

B. Turonova

SARS-CoV-2 S-Protein 3D Structure Study: What Are the Different Viru…

Columbia University's Zuckerman Institute

M. Sikora

SARS-CoV-2 3C and 3C-Like Protease Inhibitors Research: How Effectiv…

Columbia University's Zuckerman Institute

K. Chang

NYP COVID-19 Experience: How Much Clinical Ethics Consultations Rais…

Columbia University's Zuckerman Institute

K. Fischkoff

NYP COVID-19 Ethics Consultations: Does COVID-19 Disproportionately …

Columbia University's Zuckerman Institute

L. Dugdale

SARS-CoV-2 Evolutionary Spike Potential: Can We Map the Effects of a…

Columbia University's Zuckerman Institute

J. Bloom

COVID-19 Vaccine Trials Summary: Discussion and Q&A

Columbia University's Zuckerman Institute

D. Lucey

D614G Mutation in SARS-CoV-2 Spike: Is the Virus Different and More …

Columbia University's Zuckerman Institute

B. Korber

Rapid Synthetic DNA SARS-CoV-2 Vaccine Analysis: What Are the Cellul…

Columbia University's Zuckerman Institute

A. Patel

Development of a DNA SARS-CoV-2 Vaccine: What Are the Advantages of …

Columbia University's Zuckerman Institute

A. Patel

COVID-19 Vaccine Trials on 6 Continents: Which Eight Vaccine Candida…

Columbia University's Zuckerman Institute

D. Lucey

COVID-19 & School Reopening: What Test Will Allow Us to Safely Open …

Columbia University's Zuckerman Institute

A. Paltiel, R. Walensky

Can Hepatitis C Drugs Be Repurposed to Treat COVID-19? Which Drugs A…

Columbia University's Zuckerman Institute

J. Ju

Physician Distress over COVID-19 Triage Decisions: Does Training Dec…

Columbia University's Zuckerman Institute

F. Chou

COVID-19 saRNA Vaccine: Is It Possible That There Is a Cheaper and F…

Columbia University's Zuckerman Institute

R. Shattock

COVID-19 & Exacerbated Inflammatory Responses: Is Type I IFN Deficie…

Columbia University's Zuckerman Institute

B. Terrier

Moving Around During the Pandemic: Should You Use Subway or Bike? An…

Columbia University's Zuckerman Institute

J. Saldarriaga Chaux

Green Disinfectant Foams & COVID-19: Can Disinfectant Products Incre…

Columbia University's Zuckerman Institute

P. Somasundaran

Synthetic Control Analysis of Post Memorial Day COVID-19 Outbreak in…

Columbia University's Zuckerman Institute

V. Misra

SARS-CoV-2 Spike: Can We Identify Convalescent Plasma Donors With Hi…

Columbia University's Zuckerman Institute

K. Chandran

Repurposed Drugs For COVID-19: Which Drugs Are In Trials & What Are …

Columbia University's Zuckerman Institute

A. Chatterjee

COVID-19 & Pulmonary Embolism and Other Thrombotic Complications: Do…

Columbia University's Zuckerman Institute

K. Capaccione

Healing COVID-19 Lungs: How Do Stem Cells in the Lung Respond to the…

Columbia University's Zuckerman Institute

J. Que

COVID-19 Testing: How Long Is Someone Infectious Enough To Be Able t…

Columbia University's Zuckerman Institute

D. Griffin

SARS-CoV-2 Epidemiology Update: How Has the Epidemiology of the Viru…

Columbia University's Zuckerman Institute

N. Grubaugh

Global Health Vaccines for COVID-19: What Are the Non-medical Obstac…

Columbia University's Zuckerman Institute

P. Hotez

Update on Airborne Transmission of SARS-CoV-2: Can Far UV Light Help…

Columbia University's Zuckerman Institute

D. Brenner

Coronavirus Reverse Genetics: What Have We Learned From 20 Years Of …

Columbia University's Zuckerman Institute

V. Thiel

SARS-CoV-2 & Ultraviolet Disinfection: Can Far-UVC Light Efficiently…

Columbia University's Zuckerman Institute

D. Brenner

Factors that Regulate ACE2, the SARS-CoV-2 Entry Receptor: Which Cel…

Columbia University's Zuckerman Institute

J. Ordovas-Montanes

Comprehensive Analysis of COVID-19 Immunology: How Much of an Adapti…

Columbia University's Zuckerman Institute

S. Crotty

Mouse Models for COVID-19: What Do We Know About the CoV Immune Resp…

Columbia University's Zuckerman Institute

S. Perlman

Massimo Baiocchi, MD and Maria Benedetto, MD - Intensive care organi…

Columbia University's Zuckerman Institute

Simulation & Projection of COVID-19 in the US: What Is the Metapopul…

Columbia University's Zuckerman Institute

J. Shaman

Which Drugs Are Showing Actual Efficacy in Killing the Virus? A Comp…

Columbia University's Zuckerman Institute

A. García-Sastre

SARS-CoV-2: What Is the Functional and Genetic Link Between Compleme…

Columbia University's Zuckerman Institute

S. Shapira

Can We Treat COVID-19 With 3CL Protease Inhibitor?

Columbia University's Zuckerman Institute

B. Stockwell

COVID-19 Autopsies: Who Is Getting Autopsied & What Is the Benefit o…

Columbia University's Zuckerman Institute

G. Markowitz

Myocardial Injury During COVID-19: How Much Does It Affect Patient O…

Columbia University's Zuckerman Institute

N. Uriel

COVID-19 Clinical Experience: What Are the Less Known Complications …

Columbia University's Zuckerman Institute

D. Griffin

COVID-19 Comprehensive Analysis: What Is the Time Course of the Dise…

Columbia University's Zuckerman Institute

G. Hripcsak

What Can We Expect From the Daily Home Test for SARS-CoV-2 Infection…

Columbia University's Zuckerman Institute

A. Bendesky